Sort
15,842 grants matching “pancreatic cancer”
METEOR-Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)
$62,021Clifford Grant Robinson · Washington University · U54 · FY2023 · CA
Core D- Administrative Core
$61,941Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA
Core D- Administrative Core
$61,941Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Identifying phosphatidylinositol metabolism vulnerabilities in cancer pathways
$61,610Seth Zimmerman · Duke University · F32 · FY2019 · CA
The novel PRMT5-substrate adaptor interface provides a therapeutic target in MTAP null tumors
$61,610Kathleen Mulvaney · Broad Institute, Inc. · F32 · FY2019 · CA
EPIDEMIOLOGY OF CANCER MORTALITY IN CHA
$61,305Northwestern University · R03 · FY2000 · CA
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.
$61,226Jennifer E Klomp · Univ Of North Carolina Chapel Hill · F32 · FY2019 · CA
Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities
$61,174Mindy Kim Graham · Johns Hopkins University · F32 · FY2018 · CA
Role of tissue resident macrophages in development of mammary tumors
$61,174Nehemiah Cox · Sloan-Kettering Inst Can Research · F32 · FY2018 · CA
Exploring BCL-XL addiction in pancreatic ductal adenocarcinoma
$61,174Ryan Soderquist · Duke University · F32 · FY2018 · CA
NRF2 AND TXN SYSTEM-MEDIATED RESPONSE TO NADK INHIBITION IN PANCREATIC CANCER
$61,080Sarah H. Elsea · Baylor College Of Medicine · R01 · FY2019 · CA
MYC is a critical downstream effector in KRAS-driven pancreatic cancer
$60,990Brittany Allen-Petersen · Oregon Health & Science University · F32 · FY2017 · CA
Epigenetic therapy for pancreatic cancer
$60,990Gaoyang Liang · Salk Institute For Biological Studies · F32 · FY2017 · CA
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in pancreatic cancer
$60,854Jason Kwon · Dana-Farber Cancer Inst · F32 · FY2019 · CA
Characterizing and Targeting the Hypoxic T Cell Surfaceome to Promote Immune Function in Cancer
$60,854James Robert Byrnes · University Of California, San Francisco · F32 · FY2019 · CA
Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection
$60,833Katharina Schlacher · Sloan-Kettering Inst Can Research · K22 · FY2014 · CA
Mechanism of APE1 in DNA damage response
$60,762Shan Yan · University Of North Carolina Charlotte · R01 · FY2022 · CA
Core D- Administrative Core
$60,702Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Personalized Organoid-Chip Model For Drug Testing in Pancreatic Cancer
$60,641Faraz Bishehsari · Rush University Medical Center · R21 · FY2024 · CA
Investigation of Sox9 target genes in the pancreas
$60,618Rebecca Beer · Johns Hopkins University · F32 · FY2016 · DK
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
$60,494Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2016 · CA
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
$60,494Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2015 · CA
The Role of glypican-1 in Pancreatic Cancer Development and Progression
$60,482Chery Angel Whipple · Dartmouth College · F32 · FY2012 · CA
Novel Inhibitors of Akt Signaling in Pancreatic Cancer
$60,439Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Community Outreach and Engagement
$60,161Sharon L Manne · Rbhs -Cancer Institute Of New Jersey · P30 · FY2019 · CA